AccessData's AD Lab Becomes First Forensics Platform Available on AWS and Azure Cloud Environments
Company also announces plans to make AD eDiscovery software available in Cloud, other enhancements to e-discovery software tools
LINDON, Utah, Oct. 26, 2017 (GLOBE NEWSWIRE) -- AccessData Group, a leading provider of integrated digital forensics and e-discovery software, today announced that its AD Lab centralized investigations platform is now the first product in its category to be available to users in a cloud-based environment.
"As data sets in digital forensics investigations continue to grow and teams become more distributed, our customers have been asking us to offer flexible deployment options for using our software," said Victor Limongelli, chief executive officer of AccessData. "In addition to installing AD Lab onto our customers' on-premise servers, we're now able to help them leverage the scalability of the cloud as well. Customers can quickly and easily benefit from AD Lab without making any hardware investments."
AD Lab is a large-scale investigations and processing engine that enables computer forensics labs of all sizes to provide their teams with collaborative analysis, centralized case management and web-based review, thereby dramatically streamlining the investigative process.
The product is now available to customers on Amazon Web Services, a leading cloud platform for the delivery of professional software tools, and can be obtained on AWS Marketplace by clicking here. Customers will be asked to enter their AD Lab license information and will then be granted access to the software. AccessData expects to have AD Lab available on the Microsoft Azure cloud platform this quarter.
AD eDiscovery and Summation
Limongelli also announced that the company is moving forward on an initiative to make its flagship e-discovery software product, AD eDiscovery, available to customers in a cloud-based environment as well. AD eDiscovery better equips corporate IT and corporate legal teams with the needed software platform to efficiently and seamlessly conduct data collection, enterprise search, preservation, litigation holds, data processing, early data assessment and complete legal review.
Meanwhile, the company released new 6.3 versions of both AD eDiscovery and Summation, a web-based e-discovery review solution that supports the post-data collection stages of the e-discovery process and enables secure collaboration, regardless of where any member of the litigation team is located.
Most notably, the AccessData tools are now able to connect with Brainspace, the industry's leading machine learning software that leverages the power of augmented intelligence to accelerate e-discovery review. Brainspace customers can now push data from -- and pull data out of -- AD eDiscovery, in order to gain deeper insights into their data sets.
AD eDiscovery 6.3 and Summation 6.3 also feature enhancements to collect emails containing "illegal" data and migrate those files into the AccessData environment for processing, new data collector support for the latest Enterprise Vault and OneDrive environments, and the ability to create and export searchable PDFs from native files.
"These enhancements bring powerful infrastructure upgrades for improved analytics, as well as greater functionality with email collection and PDF exporting," said Limongelli.
For more information about the new versions of AccessData's e-discovery or digital forensics software products, please click here.
Whether it's for investigation, litigation or compliance, AccessData® offers industry-leading solutions that put the power of forensics in your hands. For 30 years, AccessData has worked with more than 130,000 customers in law enforcement, government agencies, corporations and law firms around the world, providing both stand-alone and enterprise-class solutions that can synergistically work together. The company is backed by Sorenson Capital, a leading private equity firm focused on high-growth portfolios. For more information on AccessData, please go to www.accessdata.com.
Vice President, Marketing
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: AccessData via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
VistaJet Partners With Christie's for the Global Tour of The Collection of Peggy and David Rockefeller22.11.2017 11:39 | Pressmeddelande
The sale will be the most significant philanthropic auction ever presented LONDON, Nov. 22, 2017 (GLOBE NEWSWIRE) -- VistaJet, the first and only global private aviation company, announces today its worldwide sponsorship of the exhibition and tour of The Collection of Peggy and David Rockefeller, the most significant auction entirely dedicated to raising funds for philanthropic causes. The sale, consisting of numerous categories, will be conducted by Christie's, the world's leading art business, and will include a highlights exhibition tour in Hong Kong, London, Los Angeles and New York. Photos accompanying this announcement are available at http://www.globenewswire.com/NewsRoom/AttachmentNg/c78fdce7-7651-42a8-a621-14088da2cc86 http://www.globenewswire.com/NewsRoom/AttachmentNg/33af2489-a9a8-4bbe-b5f7-78e4c1f29ca2 http://www.globenewswire.com/NewsRoom/AttachmentNg/a16c2
Nasdaq to Deliver Blockchain e-Voting Solution to Strate22.11.2017 10:00 | Pressmeddelande
South Africa's central securities depository (CSD) will leverage the solution to improve voting efficiencies and increase shareholder participation in South Africa STOCKHOLM, Sweden and JOHANNESBURG, South Africa, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq:NDAQ) and Strate (Pty) Ltd, the South African CSD, announced today an agreement for Nasdaq to deliver a new blockchain solution that would bring electronic voting to the South African capital markets. The solution will allow Strate, in conjunction with key stakeholders in the market, to provide general meeting services and give shareholders an easy, user-friendly and secure tool for voting remotely. The solution is based on the successful proof of concept (PoC) developed for Nasdaq's Estonia market. In addition, Strate will contribute to the ongoing market development of e-Voting technology. "We are very excited about our initiative with Nasdaq and what it means for the South African financial markets," said Tan
Immunicum AB: Invitation to Investor Events22.11.2017 08:00 | Pressmeddelande
Press release November 22, 2017 Invitation to Investor Events Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel immune-priming cancer treatment against a variety of solid tumors, today announced that CEO Carlos de Sousa will present the Company as well as provide background on the previously announced proposed Rights Issue at two upcoming investor events. Aktiespararna Stora Aktiedagen in Gothenburg Date: Monday, November 27, 2017 Presentation Time: 10:10-10:40 CET Location: Svenska Mässan, Mässans Gata 8, Gothenburg Please register to attend at https://www.aktiespararna.se/aktiviteter/stora-aktiedagen-goteborg. Immunicum Investor Event in Stockholm Date: Thursday, November 30, 2017 Presentation Time: 18:00-19:00 CET Location: United Spaces, Waterfront Building, Floor 2, Klarabergsviadukt
Immunicum AB: Inbjudan till investerarmöten22.11.2017 08:00 | Pressmeddelande
Pressmeddelande 22 november 2017 Inbjudan till investerarmöten Immunicum AB (publ), First North Premier: (IMMU.ST), ett bioteknikbolag som utvecklar nya immunaktiverande cancerbehandlingar för ett antal solida tumörer, meddelar dag att VD Carlos de Sousa kommer att presentera bolaget samt bakgrunden till bolagets föreslagna nyemission vid två kommande investerarmöten. Stora Aktiedagen i Göteborg, Aktiespararna Datum: Måndagen den 27 november, 2017 Plats: Svenska Mässan, Mässans gata 8, Göteborg Tid: Kl 10.10 - 10.40 i sal 4 Vänligen anmäl deltagande via https://www.aktiespararna.se/aktiviteter/stora-aktiedagen-goteborg. Immunicums investerarmöte i Stockholm Tid: Kl. 18.00 torsdagen 30 november 2017 Plats: United Spaces, Waterfront, Klarabergsviadukten 63 plan 2, Stockholm Det bjuds på lättare förtäring och dryck efter presentationen.
Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference21.11.2017 15:15 | Pressmeddelande
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 21, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced that Peter Wrighton-Smith, Chief Executive Officer, will present at the 29th Annual Piper Jaffray Healthcare Conference on Tuesday, November 28th, at 12:00 p.m. EST. The conference will be held at the Lotte New York Palace. A live webcast of the presentation will be available online from the investor relations page of the Company's corporate website at www.oxfordimmunotec.com. A webcast replay will be available approximately two hours after the live presentation and will be archived on the website for approximately 90 days. About Oxford Immunotec Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and comme
OmniComm Systems Signs Letter of Intent to Acquire Certain Assets of Algorithm and its Subsidiary Algorics21.11.2017 14:00 | Pressmeddelande
Acquisition Will Expand OmniComm's Product Line With Data Analytics and Risk-Based Monitoring Solutions FORT LAUDERDALE, Fla., Nov. 21, 2017 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OTCQX:OMCM), a leading global provider of clinical data management technology, and Algorithm, Inc. and its subsidiaries Algorics Ltd. and Algorithm Informatics Pvt. Ltd. (collectively, "Algorics"), have signed a letter of intent ("LOI"), under which OmniComm will acquire certain assets and assume certain liabilities of Algorics, a provider of clinical analytics solutions and software. By combining forces, the companies expect increased operating efficiency, strengthened traction in the maturing risk-based approach solution area, new marketing opportunities and an expanded portfolio of electronic data capture (EDC) solutions for the global clinical trials industry. The transaction would also provide OmniComm with an office in India, a country of growing importance in t
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum